B Cell Tolerance to Deiminated Histones in BALB/c, C57BL/6, and Autoimmune-Prone Mouse Strains by Nishant Dwivedi et al.
March 2017 | Volume 8 | Article 3621
Original research
published: 30 March 2017
doi: 10.3389/fimmu.2017.00362
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Johan Van Der Vlag, 




Radboud University Nijmegen 
Medical Centre, Netherlands 
Jurgen Dieker, 
Nijmegen Center for Molecular Life 
Sciences, Netherlands  
Ger J. M. Pruijn, 
Radboud University Nijmegen, 
Netherlands  
Elisa Corsiero, 
Queen Mary University of London, 
UK
*Correspondence:




Brigham and Women’s Hospital, 
Harvard Medical School, Boston, 
MA, USA
Specialty section: 
This article was submitted to 
Molecular Innate Immunity, 






Dwivedi N, Hedberg A, Zheng YY, 
Neeli I, Satoh M, Morel L, Rekvig OP 
and Radic M (2017) B Cell Tolerance 
to Deiminated Histones in BALB/c, 
C57BL/6, and Autoimmune-Prone 
Mouse Strains. 
Front. Immunol. 8:362. 
doi: 10.3389/fimmu.2017.00362
B cell Tolerance to Deiminated 
histones in BalB/c, c57Bl/6, and 
autoimmune-Prone Mouse strains
Nishant Dwivedi1†, Annica Hedberg2, Ying Yi Zheng3, Indira Neeli1, Minoru Satoh4, 
Laurence Morel3, Ole Petter Rekvig2 and Marko Radic1*
1 Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 
USA, 2 Medical Faculty, Department of RNA and Molecular Pathology, Institute of Medical Biology, University of Tromsø, 
Tromsø, Norway, 3 Department of Medicine, University of Florida, Gainesville, FL, USA, 4 Department of Clinical Nursing, 
University of Occupational and Environmental Health, Fukuoka, Japan
Deimination, a posttranslational modification of arginine to citrulline carried out by 
peptidylarginine deiminases, may compromise tolerance of self-antigens. Patients with 
connective tissue autoimmunity, particularly rheumatoid arthritis (RA), systemic lupus 
erythematosus (SLE), or Felty’s syndrome, present with autoantibodies to deiminated 
histones (dH), which thus form a category of antibodies to citrullinated protein antigens 
(ACPA). In general, ACPA are a sensitive diagnostic for RA and may form in response 
to the release of nuclear chromatin (DNA plus dH) from granulocytes, usually referred to 
as neutrophil extracellular traps. The aim of this study was to examine spontaneously 
autoimmune mice for autoantibodies and T cell responses to dH. We compared IgG 
binding to deiminated and non-deiminated histones (nH) by ELISA and Western blotting 
in spontaneously autoimmune strains of (NZB × NZW) F1 and NZM2410 together with 
their derivative congenic strains, C57BL/6.Sle1 and C57BL/6.Sle1.Sle3, which display 
profound autoreactivity against nuclear self-antigens. The splenocyte proliferation against 
the two antigens was determined in the spontaneously autoimmune (NZB × NZW) F1 
strain from which other autoimmune strains used in the study were derived. Immunizations 
with dH and nH were attempted in BALB/c mice to assess their splenocyte response. 
Splenocytes from BALB/c mice and from autoimmune mice at the time of conversion to 
autoimmunity proliferated strongly in response to dH, yet serum IgG from autoimmune 
(NZB × NZW) F1, NZM2410, and C57BL/6.Sle1.Sle3 mice displayed a remarkable bias 
against binding to dH. At the time of seroconversion, the antibodies already exhibited 
preference for nH, and only nH were recovered from circulating immune complexes. 
Analysis of histone deimination showed constitutive deimination in thymic extracts from 
C57BL/6 and C57BL/6.Sle1.Sle2.Sle3 triply congenic mice and in spleens of autoim-
mune triply congenic mice. Our study demonstrates that tolerance mechanisms against 
dH are intact in BALB/c and C57BL/6 mice and continue to be effective in mice with 
overt autoimmunity to nH. We conclude that, in contrast to human RA and SLE patients, 
where we frequently observe autoantibodies against dH, autoimmune mice maintain 
strong tolerance mechanisms to prevent the development of autoantibodies to dH.
Keywords: autoimmunity, antibodies to citrullinated protein antigens, citrullines, B cells, lupus erythematosus, 
rheumatoid arthritis, autophagy, tolerance
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inTrODUcTiOn
Antibodies to citrullinated protein antigens (ACPA) are diag-
nostic markers for rheumatoid arthritis (RA) (1) and also arise 
in other human autoimmune disorders such as systemic lupus 
erythematosus (SLE) and Felty’s syndrome (2, 3). Citrullines are 
introduced into proteins by peptidylarginine deiminase (PAD) 
family of enzymes (4), and much effort has been devoted to learn-
ing the circumstances that activate PADs and lead to the PAD-
mediated conversion of arginine residues into citrulline residues 
(5, 6). Several citrullinated antigens have been identified in RA, 
and a common mechanism has been proposed to account for 
the generation of citrullinated autoantigens (7–9). The proposed 
mechanism places particular importance on PAD2 and PAD4, 
enzymes that are expressed in cells of the innate and adaptive 
immune system (10, 11). These calcium-dependent enzymes 
are activated under inflammatory conditions (5). Direct stimuli 
of PADs include microbial pathogens and pro-inflammatory 
chemokines and cytokines (5). The enzymes are also activated 
by sterile inflammatory stimuli, such as cholesterol and urate 
crystals (8). In fact, it has been argued that any perforation to 
the plasma membrane could lead to the activation of PADs (12).
One particularly relevant event that is linked to PAD activa-
tion and may contribute to the induction of ACPA is a form of 
granulocyte cell death, which is induced by microbes and inflam-
matory stimuli and results in the release of nuclear chromatin 
(5, 13). Such neutrophil extracellular traps (NETs) are considered 
an innate antimicrobial response because the externalized chro-
matin is associated with neutrophil granule components such 
as myeloperoxidase and elastase, which, together with histones 
themselves, assist in bacterial killing and microbial entrapment 
(14). In the process of NET release, termed NETosis, PADs 
gain access to multiple intracellular and extracellular substrates 
such as histones, filaggrin, fibrinogen, and collagen, which are 
frequently targeted by ACPA (15). So, it is a prevalent hypothesis 
that NETosis provides conditions that lead to the production of 
deiminated (citrullinated) autoantigens that may stimulate cells 
of the adaptive immune system in the context of an inflammatory 
response. Moreover, the structural components of NETs, DNA, 
and histones, also become externalized during NETosis and, in an 
infection, may become entangled with bacteria and activate the 
immune system. Interestingly, dendritic cells respond to NETs 
with the production of interferons and other pro-inflammatory 
cytokines (16, 17). Other forms of cell death may also have 
consequences for the induction of autoantibodies, as autoanti-
bodies bind to acetylated histones, a modification of apoptotic 
chromatin that may elicit autoantibody responses in mice and 
humans (18, 19).
To provide a mouse model for the study of ACPA, we sought 
to identify spontaneous mouse models of systemic autoimmun-
ity that would produce autoantibodies to citrullinated histones. 
Although PAD4 expression parallels the severity of the inflam-
matory process in mouse models of RA (20), PAD4’s contribution 
to the production of ACPA has been more difficult to ascertain 
(21, 22). Because ACPA are difficult to induce in most strains 
of mice (23), questions have been raised whether mouse ACPA 
participate in RA pathogenesis at all (22). Human ACPA often 
react with deiminated histones (dH), and antibody binding to 
citrullinated histone peptides is a sensitive diagnostic test for 
RA (2, 24). Because histones are the major substrates of PADs 
in neutrophils, and dH are built into NETs, we expected that 
spontaneous anti-histone autoantibodies would preferentially 
bind to PAD-modified histones. However, we observed that 
mouse autoantibodies from (NZB ×  NZW) F1 (NZB/W) mice 
and their recombinant derivative strains, including NZM2410 
and C57BL/6J.Sle1 (B6.Sle1) or C57BL/6J.Sle1.Sle3 (B6.Sle1.
Sle3) congenics, showed strong preference for non-deiminated 
histones (nH) over dH by ELISA and Western blot. Thus, even 
after tolerance to histones was broken and autoantibodies to nH 
were expressed, autoimmune-prone congenic strains retained 
B cell tolerance toward dH. B cell binding to dH was repressed, 
whereas autoantibody binding focused instead on PAD4 substrate 
arginines. The B cell bias against dH argues that dH remain effec-
tive tolerogens in autoimmune mice. In support of this possibility, 
we observed elevated levels of dH in thymus extracts from B6 
and B6.Sle1.Sle2.Sle3 (B6.TC mice) and spleens of autoimmune 
B6.TC mice. Our observations suggest that, even in overtly auto-
immune lupus mice, central (thymic) tolerance inhibits B cells 
that react with a deiminated variant of an important nuclear 
autoantigen. These results point to unexpected intricacies in 
the murine immune response to deiminated autoantigens. We 




Sera were obtained from B6 mice, as well as from NZB/W, 
NZM2410, B6.Sle1, and B6.Sle1.Sle3 mice at 6–8 months of age. 
Tissues were prepared from groups of matched B6 and B6.TC mice 
of 4–6 months of age. Splenocytes were isolated from 6 BALB/c 
mice of 4 months of age and 13 NZB/W F1 female mice that were 
divided into 3 age groups: 6–10  weeks of age, 20–21  weeks of 
age, and 25–30 weeks of age. The treatment and care of animals 
were in accordance with the guidelines of the Office of Research, 
UTHSC, the University of Florida and the Norwegian Ethical and 
Welfare Board, and the study overall was approved by UTHSC 
Institutional Animal Care and Use Committee under the protocol 
#11-164.
elisa
For binding assays, we treated purified calf-thymus histones with 
recombinant PAD4 in  vitro, as described previously (2, 3). To 
assess the extent of deimination, we analyzed the progress of the 
reaction by colorimetry of citrullines and testing the resulting 
dH by Western blot with an antibody to citrullinated histone 
H3 (Abcam, ab#5103). The results of this analysis are shown in 
Figure 1.
Flat bottom, 96 well microtiter plates (Immulon 4HBX; 
Thermo Electron Corp.) were coated overnight with 5  μg/ml 
of nH, poly l-lusine, bovine serum albumin (BSA) (Sigma), 
ovalbumin (OVA) (Sigma), protamine sulfate (Sigma), or dH, as 
previously described (25). Plates were washed three times with 
FigUre 1 | In vitro deimination of histones by peptidylarginine 
deiminase (PaD) 4. Calf-thymus histones (0.1 mM) were incubated with 
0.2 µM of recombinant PAD4 for up to 24 h, and nanomoles of citrulline 
produced were determined by colorimetry at 595 nm using citrulline standard 
solution (a). Calf-thymus histones from time points tested above were 
probed on Western blot with a commercial antibody that reacts against the 
amino terminus of histone H3 with citrullines at positions 2, 8, and 17 
(Abcam, ab#5103). Deimination was detected at each time point except at 
time = 0 and increased from 0.5 to 24 h (B). The reaction reached a plateau 
by 24 h, and we calculated that 1.3 citrullines were present, on average, per 
histone H3 molecule.
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0.05% Tween-20 in PBS and blocked with 2.5% BSA in 0.02% 
NaN3 and PBS for 2 h. A 1:100 initial dilution of primary sera 
along with threefold serial dilutions in 1.6% Tween-20 and 1% 
BSA in PBS were incubated for 1 h in the plates. Then, serum dilu-
tions were removed, and wells were washed with 0.1% Tween-20 
in PBS. Alkaline phosphate-conjugated goat anti-mouse kappa 
(Southern Biotech) was added at 1:1,000 dilution in 1% BSA with 
0.05% Tween-20 in PBS for 1 h. Phosphatase substrate (Sigma) 
was used to develop the ELISA, and OD values were read at 
405 nm on a Multiscan Plus plate reader (Labsystems).
Serum antibodies against dsDNA were detected by ELISA 
exactly as described (26, 27). In short, calf-thymus dsDNA 
(10 μg/ml in PBS) was coated on microtiter plates (MaxiSorb; 
Nunc, Copenhagen, Denmark). Sera from mice were diluted 
twofold from 1:100 to 1:3,200 in PBS containing 0.02% Tween-
20 and incubated in wells. ELISA readings were obtained with 
peroxidase-conjugated rabbit anti-mouse Fc-γ antibodies at 
405 nm.
Ex Vivo Tissue lysate Preparation
Seven-month-old B6.TC autoimmune female mice and 
age-matched control B6 IgHa were dissected to recover a por-
tion of spleen, bone marrow, kidney, and liver. Thymi from 
4- to 6-month-old mice were similarly obtained. Tissue was cut, 
minced with scissors, and crushed between two sterile frosted 
glass slides. Dissociated tissues were washed in PBS (without 
Ca++) and centrifuged at 5,000 × g for 5 min to pellet cells. Cell 
pellets were mixed with lysis buffer (65mM Tris pH 7.2, 2%SDS, 
10% glycerol), containing protease inhibitors. To test for dH in 
tissue lysates, equal amounts of total protein were analyzed by 
Western blotting, as described below.
Western Blot
For Western blot analysis, proteins were resolved on 15% 
SDS-PAGE and transferred to nitrocellulose. Membranes were 
blocked in 5% BSA in 0.1% Tween-20 in TBS (TBST) overnight 
at 4°C. Subsequently, the membranes were incubated with sera at 
1:500 dilution in TBS containing 2.5% BSA, 1% NP-40, and 0.1% 
SDS. After 2 h of incubation, membranes were washed with 1% 
NP-40 in TBS. Anti-mouse IgG–HRP was used for detection at 
1:20,000 dilution in TBST for 1 h, and blots were developed using 
chemiluminescence (PerkinElmer).
Peptide inhibition assays included a preceding step, in which 
3 µg of 20-mer peptides, both matching the amino terminus of 
H3 but either containing arginines or citrullines at positions 2, 8, 
and 17, were incubated with 1:300 dilutions of mouse sera for 1 h 
prior to use in binding to dH and nH on the membrane. Results 
of these Western blots were quantitated by infrared emission 
of secondary anti-mouse IgG antibodies (Odyssey). Separately, 
autoimmune sera were treated with DNase1 prior to Western 
blotting. Briefly, 400 μl of a 1:200 dilution of sera were incubated 
with 20 units of DNase1 (New England Biolabs) for 1 h at room 
temperature to limit the possibility that DNA–anti-DNA com-
plexes present in sera contribute to the observed histone binding. 
Following this incubation, the sera were diluted 1:500 in Western 
blot binding buffer.
To probe for deiminated histone H3 (dH3) in B6.TC and B6 
mice, equal amounts of tissue lysates were resolved on 12% SDS-
PAGE and transferred to nitrocellulose. Membranes were blocked 
with 5% BSA in TBST for 30 min and incubated with anti-dH3 
anti-citrullinated histone H3 rabbit antibodies (Abcam, ab#5103) 
overnight at 4°C. Membranes were washed and incubated with 
HRP-conjugated goat-anti-rabbit secondary IgG antibody for 1 h 
at room temperature, washed three times in TBST, and twice in 
TBS alone. The HRP activity was detected as above.
splenocyte Proliferation assay
BALB/c mice were boosted twice with 100 µg of total histones 
(dH or nH) or 100 µg OVA, 14 and 2 days prior to the splenocyte 
proliferation assay. Ninety-six well tissue culture plates (Corning 
Incorporated) were filled with 100 µl aliquots of 100 µg/ml (or 
threefold serial dilutions) of dH, nH, or OVA in RPMI 1640 
(Mediatech Inc.) supplemented with 10% FBS. Splenocytes were 
isolated and resuspended in RPMI with 10% FBS at 1 × 106 cells/ml. 
One hundred microliters of cell suspension was added to each 
well, and plates were incubated at 37°C in 5% CO2 for 72 to 96 h. 
Tritiated thymidine (1 μCi/well) was added for the last 17 h of 
incubation. Plates were harvested onto glass fiber filters, and 
thymidine incorporation was assessed by scintillation count-
ing. Splenocyte proliferation assays were also performed using 
4Dwivedi et al. Tolerance to dH
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female NZB/W mice purchased from the Jackson Laboratory 
(Bar Harbor, ME, USA). Splenocytes were collected from NZB/W 
mice of different ages. Following red blood cell lysis, the spleno-
cytes were resuspended in DMEM-10 media with 10% FCS and 
10,000 U/ml penicillin and 10 mg/ml streptomycin. One hundred 
thousand cells were incubated with dH or nH (20 μg/ml of pro-
tein) in triplicate wells. Tritiated thymidine incorporation (1 μCi/
well) was measured after 20 h, 3 or 6 days by liquid scintillation, 
as described (28, 29).
resUlTs
spontaneously arising anti-histone 
autoantibodies
To assess the production of anti-nH/dH autoantibodies in 
mice that spontaneously develop antinuclear autoantibodies, 
we tested sera from NZB/W and their recombinant inbred 
derivative strain NZM2410 for binding to nH and dH. In 
addition, we tested the contribution of lupus-predisposing 
genetic intervals Sle1 and Sle3 that were back-crossed from 
the NZM2410 onto the B6 background (B6.Sle1 and B6.Sle1.
Sle3). Sle1 is a locus that breaks tolerance to chromatin, 
whereas Sle3 affects functions of myeloid cells (30). The 
parental strains, NZB and NZW, have distinct MHC, H-2d 
and H-2z, respectively. The lupus-predisposing H-2z was 
maintained in the NZM2410 congenics, whereas the Sle1 and 
Sle3 congenics have the H-2b from B6. Antibody binding to 
dH and nH was assessed by ELISA (Figure 2) and Western 
blot (Figure 3). As controls, sera from age- and sex-matched 
B6 mice were used.
By ELISA, NZB/W (Figure 2A), B6.Sle1 (Figure 2B), B6.Sle1.
Sle3 (Figure 2C), and NZM2410 (Figure 2D) sera showed prefer-
ence for nH over dH. This preferential binding was statistically 
significant for NZB/W, NZM2410, and B6.Sle1.Sle3, as assessed 
by paired, one-tailed T-test. Binding differed for different mice 
and dilutions but, in general, binding to nH was stronger than 
the binding to dH. We also confirmed the additive effect of Sle1 
and Sle3 loci, as the B6.Sle1.Sle3 combination resulted in greater 
absorbance values relative to the B6.Sle1 mice. In parallel assays, 
sera from B6 mice (Figure 2E) showed no reactivity to histones. 
Both dH and nH were present in equivalent concentrations on 
the plates, as shown by the nearly identical binding of the LG2.2 
monoclonal antibody (Figure  2F) whose epitope, the first 13 
amino acid residues of histone H2B, is identical between nH and 
dH (31).
To examine the possibility that antibodies to dH arise first 
but are replaced by antibodies to nH, we collected mouse sera 
over time to identify mice during the conversion to anti-histone 
autoimmunity. In Figure 2G, we show that binding preference 
to nH over dH was present at an early time when anti-histone 
reactivity first appeared. This result indicates the two reactivities 
arise jointly, rather than in succession, as might be predicted by 
epitope spreading.
To dissect the preferential binding to nH, we used Western 
blotting. The stringency of binding was increased by including 
both SDS (0.05%) and NP-40 (0.5%) in the binding buffer. 
Indeed, under these conditions, the binding of serum antibodies 
from NZB/W, NZM2410 B6.Sle1, and B6.Sle1.Sle3 mice to dH 
was weaker relative to the binding to nH, such that many of 
the sera bound exclusively to nH (Figure  3A). A variety of 
binding patterns were observed, including exclusive binding 
to one or two core histones. Binding to dH3 was observed 
most often, whereas binding to deiminated H4 or H2A was 
rare. In  addition, binding to a band with the mobility of the 
deiminated linker histone H1 was observed in several blots. 
Overall, binding was more biased toward nH over dH, although 
some IgG dH was also observed in individual NZM2410 and 
B6.Sle1.Sle3 mice. In no instance did binding to nH exceed 
binding to dH.
To examine the possibility that the binding to dH represented 
a truly separate population of antibodies, we conducted inhibi-
tion experiments using 20-mer peptides that matched the amino 
terminus of histone H3 and either contained arginines or citrul-
lines at positions 2, 8, and 17 (Figure 3B). We observed that the 
arginine-containing peptide (orange bars) was a more effective 
inhibitor of binding to both nH and dH, relative to the citrulline-
containing peptide (blue bars), suggesting that the antibody 
binding to either antigen reflects antibody specificity for nH and 
that the binding to dH likely represents cross-reactivity due to 
shared epitope structure.
splenocyte Proliferation
We asked whether T  cells from autoimmune mice also recog-
nize dH by using NZB/W mice that spontaneously develop an 
autoimmune response against nuclear Ags, including DNA and 
histones (32). Splenocytes from NZB/W mice of different ages 
were tested for proliferation in the presence of dH or nH. At 
6–10 weeks of age, prior to any measurable anti-DNA reactivity, 
the splenocytes did not proliferate in response to either form 
of histone (Figures  4A,B). At 20–21  weeks of age, anti-DNA 
autoantibodies could be detected in the sera of some NZB/W 
mice (indicated at the top of each panel), and splenocytes from 
these mice showed low levels of proliferation in response to nH 
and dH (Figures 4C,D). Thus, splenocyte responses to histones 
arose in parallel with, or slightly prior to, humoral responses to 
DNA.
Twenty-five-week-old NZB/W mice with established autoim-
munity showed splenocyte proliferation in response to dH and 
nH (Figures 4E,F), suggesting the presence of histone-reactive 
T  cells in the spleens of autoimmune mice. Although some 
mice showed a tendency to preferentially respond to dH, others 
preferred nH, as shown by data from two of the analyzed mice. 
Notably, preference could switch, depending on the length of 
stimulation (Figures 4E,F), suggesting the presence of a limited 
number of T  cell clones with distinct specificities and growth 
characteristics. Because proliferation generally showed a bias for 
dH or nH rather than being equal, we infer that epitopes contain-
ing arginines or citrullines were both presented by the MHC and 
recognized by T cells in splenocytes.
To examine the ability of dH to drive a T  cell response, we 
examined T cell proliferation in vitro. Splenocytes from BALB/c 
mice immunized with dH proliferated during incubation with 
dH (Figure 4G) to comparable extent as splenocytes from mice 
FigUre 2 | Binding of igg from autoimmune-prone and control mice to non-deiminated histones (nh) and deiminated histones (dh). Sera from NZB/W 
(a), B6.Sle1 (B), B6.Sle1.Sle3 (c), NZM2410 (D), and control B6 (e) mice were tested for IgG binding to nH and dH. Complete binding curves were obtained, and 
OD values for a single dilution were plotted in panels (a–D). We plotted data from 1:1,000 dilutions in panels (a–c) and from the 1:200 dilution in panel (D). 
Absorbance values for each serum corresponding to IgG binding to dH and nH are shown and are connected by a line indicating the pairs of data for the binding of 
each serum to the two antigens. Significance of the readings was tested by paired, one-tailed T-test. Binding to dH was significantly less than to nH for NZB/W 
(p < 0.0001), NZM2410 (p < 0.016), and B6.Sle1.Sle3 (p < 0.016). The binding of B6.Sle1 IgG tended to be lower to dH (p < 0.10). IgG from mice with systemic 
lupus erythematosus susceptibility genes showed preferential binding to nH. In comparison, control B6 mice showed negligible binding to either form of histones (e). 
As control for equal coating of Ags, we used LG2-2, a mouse anti-histone H2B mAb (F), whose epitope does not include any residues that are substrates for 
deimination (31). Thus, the binding curves for dH (filled symbols) and nH (open symbols) are nearly superimposable. Individual mice were followed over time (g), to 
observe the initial development of anti-histone autoreactivity. Two NZB/W mice that first showed anti-histone reactivity at 4 months of age (September) reacted more 
strongly to nH than to dH, and the preferential antibody binding was maintained at 5 months of age (October). The sera were diluted 1:300, and the measurements 
were performed three times with consistent results. The Y-axis displays values of optical density measured by ELISA.
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immunized with OVA and incubated with OVA (Figure 4I). By 
contrast, splenocytes from BALB/c mice immunized with nH 
showed no enhanced proliferation regardless of whether they 
were incubated with dH, nH, or media alone (Figure 4H).
spleens of autoimmune Mice have 
increased levels of dh
To test for the presence of dH in vivo, we prepared tissue lysates 
of bone marrow, spleen, liver, kidney, and thymus from B6.TC 
FigUre 3 | continued
6
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FigUre 4 | Proliferation of splenocytes from nZB/W and immunized BalB/c mice. Splenocytes derived from NZB/W mice of different ages were tested for 
dsDNA binding by ELISA (a–F). In parallel, splenocytes were stimulated with deiminated histones (dH) or non-deiminated histones (nH) in vitro, as indicated. 
Proliferation was assessed following 4 h, 3 and 6 days in culture, and the response was determined by [3H] thymidine incorporation. In addition, splenocytes from 
mice immunized with dH (g) or nH (h) were tested for proliferation in response to dH or nH, or ovalbumin (i) as control. The results are presented as stimulation 
indices (SI) that were calculated from mean cpm values of triplicate wells. The significance of differences between samples was determined by unpaired T-test, and 
the p values are indicated.
FigUre 3 | continued 
Western blot of igg to deiminated histones (dh) and non-deiminated histones (nh). Equal amounts of dH and nH were resolved on SDS-PAGE, transferred 
to nitrocellulose, and stained with Ponceau red (upper left panel). The stained bands migrating with the mobilities of core and linker histones are indicated along the 
margins. Note that due to the replacement of the positively charged arginine by the neutral citrulline, the electrophoretic mobility of certain core histones is increased 
in the dH sample, indicating nearly complete modification by peptidylarginine deiminase 4. (a) Strips of membrane containing nH or dH were probed with NZB/W, 
NZM2410, B6.Sle1, and B6.Sle1.Sle3 sera at 1:500 dilution and developed with anti-mouse IgG-horseradish peroxidase. Autoimmune-prone mouse sera bound nH 
in preference to dH. The experiments were performed at least three times with consistent results. (B) To explore whether the binding to histones on the membranes 
is equally sensitive to inhibition by 20-mer peptides matching the H3 amino terminus and containing arginine residues (nH peptide; orange bars) versus citrulline 
residues (dH peptide; blue bars) at positions 2, 8, and 17, we preincubated an NZB/W serum that showed binding to both nH and dH (black bars) with either 
peptide, as described in Section “Materials and Methods,” and carried out the Western blots. The nH peptide was a more effective inhibitor of binding to both 
histones than the dH peptide. The Y-axis indicates binding intensities in units of infrared emission (IE).
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mice and probed them with anti-dH by Western blot. The bone 
marrow lysates of autoimmune B6.TC mice and control mice 
at 7 months of age did not appreciably react with antibodies to 
dH3 (Figure 5A). By contrast, spleens of B6.TC mice had clearly 
increased levels of dH3 as compared to B6 controls or lysates of 
the Jurkat lymphoma cells (Figure 5B). These results provide a 
FigUre 5 | Western blot detection of deiminated histone h3 (dh3) in 
mouse tissues. Equal amounts of freshly prepared lysates from bone 
marrow (a), spleen (B), kidney (c), liver (D), and thymus (e) of autoimmune 
B6.TC and control B6 mice were blotted onto nitrocellulose membranes and 
probed with anti-dH3 antibody. Tissues from three mice were tested in each 
group. As control, Jurkat lymphoma cells were used (B). The same blots 
were also re-probed with an antibody that recognizes total histone H3 (Pan 
H3) to confirm equal loading of lysates.
8
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qualitative estimate rather than a precise measure of deimina-
tion. This is by necessity, as the cellular composition and disease 
process may affect histone deimination in a complex manner in 
a tissue such as the spleen. The overall amounts of histone H3 
were similar in all samples, as indicated by the equivalent immu-
noreactivity of an anti-H3 antibody. Therefore, the spleens of 
autoimmune B6.TC mice contained increased quantities of dH3. 
In addition, the kidneys and the liver from individual autoim-
mune mice exhibited increased levels of dH3 (Figures  5C,D). 
Importantly, thymic extracts from 4- to 6-month-old B6 and 
B6.TC mice clearly showed constitutively elevated levels of dH 
(Figure 5E).
DiscUssiOn
In this study, we observed that autoimmune mice exhibit a strik-
ing B cell bias toward binding nH over dH, a bias that is present 
at the earliest stages of anti-histone autoimmunity (Figure 2G). 
In 28 of 28 autoimmune NZB/W, NZM2410, B6.Sle1, and B6.Sle1.
Sle3 mice that made IgG anti-histone antibodies, preference was 
invariably in favor of nH (Figure 3A). Even more strikingly, in 18 
animals that produced antibodies to nH, immunoblotting could 
not detect antibodies to dH. To exclude the possibility that anti-
dH antibodies are only transiently expressed, or ensconced in 
immune complexes, we carried out longitudinal antibody-binding 
assays that consistently revealed preferential or exclusive binding 
to nH (Figure  2G). These results indicate that, even in mouse 
strains that spontaneously convert to autoimmunity, deimination 
reduces IgG binding to histones, and autoantibody binding is 
focused on arginine-containing epitopes that are absent from dH. 
It follows that dH remain effective tolerogens even after develop-
ment of autoimmunity in the tested mouse strains. We conclude 
this is an important characteristic of autoimmune mice, and we 
propose that a more detailed comparison with autoimmune dis-
ease patients may shed light on the induction of autoimmunity. 
Moreover, we argue that the specific regulation of PAD4 underlies 
these results.
Peptidylarginine deiminase 4 is most abundant in granu-
locytes and other cells of the innate immune system. However, 
PAD4 is also expressed in another immunologically relevant 
context. In elegant studies, Ireland and Unanue described the fact 
that antigen-presenting cells in mice express PAD4 and PAD2 
in a compartment that is regulated by proteins in the autophagy 
pathway (33). The deiminase activity is constitutively expressed 
in dendritic cells and macrophages, whereas it is inducible in 
B cells by stress or stimulation through the Ig antigen receptor 
(33). The authors reported that arginine residues in antigenic 
peptides are converted to citrullines, and that T cells respond to 
target antigenic epitopes containing citrulline. This mechanism 
was demonstrated by using foreign antigens, in their case, hen 
egg lysozyme that was administered in a conventional immuni-
zation. The resulting T cell clones bound preferentially, or even 
exclusively citrullinated lysozyme peptides. Our results support 
this mechanism because splenocytes from BALB/c mice prolifer-
ated as vigorously against dH as against OVA (Figure 4G versus 
Figure  4I). By contrast, splenocytes from NZB/W mice, after 
these mice had converted to autoimmunity, showed comparable 
proliferation to either antigen (Figures 4E,F). This fundamental 
difference in outcome points to differences in immunized versus 
spontaneous autoimmune responses to nH.
As further shown by Ireland and Unanue, autophagy induc-
tion in B cells is necessary for their inducible expression of PAD4 
activity associated with antigen processing (33). Conversely, a 
transient or sustained impairment of autophagy in B cells could 
provide conditions that would support the presentation of histone 
epitopes lacking citrullines. Under these conditions, B cells would 
express peptide epitopes that could act as neo-antigens for T cells 
and solicit T cell help. Autophagy has been linked by genetics to 
autoimmunity (27). A contribution of the autophagic processes 
to autoimmunity is consistent with the deficient or impaired 
functions of ATG5 (and other components of non-canonical 
autophagy) in SLE, but the mechanism for this relationship is 
unclear (27, 28). Our data suggest that effective autophagy may 
be required to maintain certain aspects of immune tolerance in 
mice.
However, an unanswered question is whether deiminated 
peptide presentation also occurs during thymic development, 
and whether tolerizing peptides expressed by thymic antigen-
presenting cells are also deiminated. In support of this possibility, 
we found that thymus lysates from B6 and B6.TC mice show 
abundant histone deimination (Figure 5E), a result that suggests 
antigen presentation in the mouse thymus is tightly linked to 
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deimination. If so, citrulline-containing epitopes of autoantigens 
such as histones may induce powerful tolerance in mice. In that 
scenario, only B  cells that bound to nH and presented non-
deiminated epitopes would break tolerance and receive T cell help. 
Consequently, autoimmunity might initially be directed against 
non-deiminated peptides, provided that B cells, at an early stage 
of autoimmune pathogenesis, suspend or shut off the deimination 
of processed epitopes. Support for this alternative comes from 
the consistent anti-nH response that we observed in numerous 
autoimmune mice from different autoimmune strains (Figures 1 
and 2). Thus, only B cells that no longer expressed PAD4 activity 
in their antigen processing compartment may escape tolerance. 
Our hypothesis of the key dependence of self-tolerance on the 
adequate function of autophagy for the presentation of dH pep-
tides is in line with the remarkable preference of autoimmune 
mouse antibodies for nH. As corollary, a steady-state balance 
between nH and dH may be maintained under pre-autoimmune 
conditions, but an imbalance between the supply, processing, 
or recognition of nH, likely coincident with a disturbance of 
autophagic antigen processing in B cells, may result in an antigen-
specific response to nH that may break immune tolerance and 
result in a sustained autoimmune response to nH.
To conclude, we briefly address the difference between mice 
and humans in their ability to express antibodies to dH. As we 
and others have shown, autoantibodies in various human autoim-
mune conditions preferentially bind dH (3, 24, 34), in striking 
contrast with the opposite bias in mice. Again, the key may be 
in the expression of PAD4 activity in B cells. Our tissue expres-
sion results indicate the increased presence of dH in the spleens 
of autoimmune mice (Figure  5B). By contrast, healthy human 
B cells appear incapable of expressing PAD4, as indicated by data 
in the Human Protein Atlas (35). There, evidence suggests that 
human B cells, even after B cell antigen engagement in the white 
pulp, fail to express detectable PAD4. Thus, expression of dH 
epitopes on human B cells may not be intrinsic to the B cells, and 
presentation of dH epitopes may not engender tolerance that it 
is as effective as it is in mice. Consequently, B cell presentation 
of deiminated peptides in humans may be more likely to break 
tolerance and lead to ACPA generation.
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